A conversation with Azul Bio Synopsis: Back to Blue’s lead editor, Naka Kondo speaks to Ben Alva, the founder of Azul Bio, a startup developing microbiome-based treatments and probiotics from nature that give ocean life immunity to human impact, such as coral resilience. They are planning their first pilot in November.
From robots and AI modelling tools to nature-based innovations, startups and academic research teams are helping monitor changes to the ocean and restore this vital ecosystem to its optimal state.
Reading time: 6mins
Reading time: 6mins
Reading time: 6mins
Reading time: 6mins
Reading time: 6mins
Reading time: 4mins
Reading time: 9mins
Reading time: 9mins
Thank you for your interest in Back to Blue, please feel free to explore our content.
If you would like to co-design the Back to Blue roadmap or have feedback on content, events, editorial or media-related feedback, please fill out the form below. Thank you.
Back to Blue is an initiative of Economist Impact and The Nippon Foundation, two organisations that share a common understanding of the need to improve evidence-based approaches and solutions to the pressing issues faced by the ocean, and to restoring ocean health and promoting sustainability